BNCT
About
Products
News
Frontier
Contact
CN
Events
News Room
2022.03.25
Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center
News
Happy 2022 and everything goes well
2021.12.31
451
News
Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China
2021.11.10
441
News
Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference
2021.10.01
628
News
The Xiamen BNCT Center and Neuboron BNCT Group
2021.09.07
214
News
Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021
2021.03.19
984
News
China’s First BNCT Center Makes Debut
2021.02.09
988
News
Neuboron Medtech, a BNCT total solution provider, enters Joint-Venture Agreement with TAE Life Sciences, further consolidating Neuboron’s global influence
2020.12.09
790
News
Neuboron Attends IAEA Technical Meeting on BNCT
2020.08.16
785
News
Device Installation Starts at China's First Accelerator-based BNCT Center
2020.08.14
772
News
Japan Tests BNCT on Unbeatable Cancers and Includes It into Medical Insurance
2020.06.01
903
News
The 2nd International BNCT Development Forum Is Delayed
2020.05.27
407
News
China's First Accelerator-based BNCT Center Capped
2020.04.15
714
News
The 2nd International BNCT Development Forum Xiamen Session to Open (Updated: January 15, 2020)
2020.01.15
704
News
BNCT in the Spotlight at the 1st China Conference on Cancer Particle Therapy Engineering Technology
2019.11.29
604
上一页
1
2
下一页
